A novel SLTM::RUNX1 acquired during CML progression and the clinical significance of concurrent BCR::ABL1 and RUNX1 rearrangements in Ph-positive leukemia.
- DOI
- 10.1016/j.cancergen.2026.10.008
- Published
- 2026 Oct 31
- Container
- Cancer genetics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cancergen.2026.10.008,
title = {A novel SLTM::RUNX1 acquired during CML progression and the clinical significance of concurrent BCR::ABL1 and RUNX1 rearrangements in Ph-positive leukemia.},
author = {Koduru P and Xu J and Yu L and Chen W and Fuda F and Madanat Y and Wilson K and Garcia R},
year = {2026},
journal = {Cancer genetics},
doi = {10.1016/j.cancergen.2026.10.008},
url = {https://doi.org/10.1016/j.cancergen.2026.10.008}
}RIS
TY - JOUR TI - A novel SLTM::RUNX1 acquired during CML progression and the clinical significance of concurrent BCR::ABL1 and RUNX1 rearrangements in Ph-positive leukemia. AU - Koduru P AU - Xu J AU - Yu L AU - Chen W AU - Fuda F AU - Madanat Y AU - Wilson K AU - Garcia R PY - 2026 JO - Cancer genetics DO - 10.1016/j.cancergen.2026.10.008 UR - https://doi.org/10.1016/j.cancergen.2026.10.008 ER -
APA
P, K., J, X., L, Y., W, C., F, F., Y, M., K, W., & R, G. (2026). A novel SLTM::RUNX1 acquired during CML progression and the clinical significance of concurrent BCR::ABL1 and RUNX1 rearrangements in Ph-positive leukemia.. Cancer genetics. https://doi.org/10.1016/j.cancergen.2026.10.008
Source records
- pubmed · retrieved 2026-11-10T17:59:54.803Z
- europe-pmc · retrieved 2026-11-10T17:59:54.811Z